JPMorgan Chase & Co’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.3M Sell
1,256,581
-101,021
-7% -$3.16M ﹤0.01% 1335
2025
Q1
$45.5M Buy
1,357,602
+707
+0.1% +$23.7K ﹤0.01% 1218
2024
Q4
$53.2M Buy
1,356,895
+380,112
+39% +$14.9M ﹤0.01% 1143
2024
Q3
$38.5M Buy
976,783
+905,129
+1,263% +$35.6M ﹤0.01% 1321
2024
Q2
$2.79M Buy
71,654
+35,033
+96% +$1.37M ﹤0.01% 2879
2024
Q1
$1.58M Sell
36,621
-16,167
-31% -$696K ﹤0.01% 3301
2023
Q4
$2.43M Buy
52,788
+2,491
+5% +$115K ﹤0.01% 3022
2023
Q3
$1.72M Sell
50,297
-28,920
-37% -$988K ﹤0.01% 3082
2023
Q2
$3.05M Buy
79,217
+46,430
+142% +$1.79M ﹤0.01% 2798
2023
Q1
$1.17M Buy
32,787
+30,700
+1,471% +$1.1M ﹤0.01% 3360
2022
Q4
$82K Sell
2,087
-2,184
-51% -$85.8K ﹤0.01% 4559
2022
Q3
$155K Buy
4,271
+1,825
+75% +$66.2K ﹤0.01% 4272
2022
Q2
$74K Sell
2,446
-3,925
-62% -$119K ﹤0.01% 4748
2022
Q1
$194K Buy
6,371
+1,596
+33% +$48.6K ﹤0.01% 4462
2021
Q4
$149K Buy
4,775
+1,761
+58% +$55K ﹤0.01% 4669
2021
Q3
$46K Buy
3,014
+975
+48% +$14.9K ﹤0.01% 4979
2021
Q2
$38K Sell
2,039
-4,466
-69% -$83.2K ﹤0.01% 5011
2021
Q1
$116K Buy
6,505
+6,447
+11,116% +$115K ﹤0.01% 4616
2020
Q4
$1K Buy
+58
New +$1K ﹤0.01% 4838
2020
Q3
Sell
-96,372
Closed -$1.21M 5047
2020
Q2
$1.21M Buy
96,372
+46,253
+92% +$580K ﹤0.01% 2923
2020
Q1
$568K Sell
50,119
-8,474
-14% -$96K ﹤0.01% 3244
2019
Q4
$768K Buy
58,593
+37,461
+177% +$491K ﹤0.01% 3219
2019
Q3
$190K Sell
21,132
-12,462
-37% -$112K ﹤0.01% 3768
2019
Q2
$332K Sell
33,594
-62,810
-65% -$621K ﹤0.01% 3549
2019
Q1
$979K Sell
96,404
-93,407
-49% -$949K ﹤0.01% 3035
2018
Q4
$1.2M Buy
189,811
+181,381
+2,152% +$1.14M ﹤0.01% 2932
2018
Q3
$111K Buy
+8,430
New +$111K ﹤0.01% 4078
2017
Q4
Sell
-9,226
Closed -$27K 4741
2017
Q3
$27K Sell
9,226
-1,590
-15% -$4.65K ﹤0.01% 3921
2017
Q2
$34K Buy
10,816
+7,200
+199% +$22.6K ﹤0.01% 3817
2017
Q1
$14K Buy
+3,616
New +$14K ﹤0.01% 4153
2016
Q4
Sell
-1,700
Closed -$14K 4555
2016
Q3
$14K Buy
1,700
+1,589
+1,432% +$13.1K ﹤0.01% 3807
2016
Q2
$1K Buy
+111
New +$1K ﹤0.01% 4184